{"abstract":"The National Heart, Lung, and Blood Institute (\"NHLBI\"), an institute of the National Institutes of Health; an agency within the Department of Health and Human Services, is contemplating the grant of an exclusive patent license to commercialize the invention(s) embodied in the intellectual property estate stated in the Summary Information section of this notice to United Therapeutics Corporation (\"United\") located in Silver Spring, MD and incorporated under the laws of Delaware.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/12/29/2016-31437.html","cfr_references":[],"citation":"81 FR 96023","comment_url":null,"comments_close_on":"2017-01-13","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NHLBI Office of Technology Transfer and Development on or before January 13, 2017 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2016-31437","effective_on":null,"end_page":96023,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/12/29/2016-31437.xml","html_url":"https://www.federalregister.gov/documents/2016/12/29/2016-31437/prospective-grant-of-exclusive-patent-license-development-and-commercialization-of-nitrite-salts-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-31437?publication_date=2016-12-29","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-12-29/2016-31437/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":77,"last_updated":"2026-10-25 06:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-12-29/pdf/2016-31437.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-31437.pdf?1482932749","publication_date":"2016-12-29","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/12/29/2016-31437.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T20:47:22Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":96023,"subtype":null,"title":"Prospective Grant of Exclusive Patent License: Development and Commercialization of Nitrite Salts for the Treatment, Amelioration, and Prevention by Any Route of Administration of Pulmonary Hypertension, Including All WHO Classifications of Pulmonary Hypertension, e.g., Groups 1-5","toc_doc":"Development and Commercialization of Nitrite Salts for the Treatment, Amelioration, and Prevention by any Route of Administration of Pulmonary Hypertension, Including All WHO Classifications of Pulmonary Hypertension, e.g., Groups 15","toc_subject":"Prospective Grants of Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":81}